BE755071A - Procede de resolution de la dl-5-/3-(terbutylamino)-2- hydroxy-propoxy/-3,4-dihydro-1(2h) naphtalenone - Google Patents

Procede de resolution de la dl-5-/3-(terbutylamino)-2- hydroxy-propoxy/-3,4-dihydro-1(2h) naphtalenone

Info

Publication number
BE755071A
BE755071A BE755071DA BE755071A BE 755071 A BE755071 A BE 755071A BE 755071D A BE755071D A BE 755071DA BE 755071 A BE755071 A BE 755071A
Authority
BE
Belgium
Prior art keywords
terbutylamino
naphthalenone
propoxy
resolving
dihydro
Prior art date
Application number
Other languages
English (en)
French (fr)
Inventor
J Shavel
C F Schwender
Original Assignee
Warner Lambert Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication date
Publication of BE755071A publication Critical patent/BE755071A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE755071D 1969-09-17 Procede de resolution de la dl-5-/3-(terbutylamino)-2- hydroxy-propoxy/-3,4-dihydro-1(2h) naphtalenone BE755071A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85924469A 1969-09-17 1969-09-17

Publications (1)

Publication Number Publication Date
BE755071A true BE755071A (fr) 1971-02-22

Family

ID=25330421

Family Applications (1)

Application Number Title Priority Date Filing Date
BE755071D BE755071A (fr) 1969-09-17 Procede de resolution de la dl-5-/3-(terbutylamino)-2- hydroxy-propoxy/-3,4-dihydro-1(2h) naphtalenone

Country Status (13)

Country Link
US (1) US3649691A (cg-RX-API-DMAC7.html)
JP (1) JPS494218B1 (cg-RX-API-DMAC7.html)
BE (1) BE755071A (cg-RX-API-DMAC7.html)
BR (1) BR7022215D0 (cg-RX-API-DMAC7.html)
CH (1) CH540882A (cg-RX-API-DMAC7.html)
DE (1) DE2046043C3 (cg-RX-API-DMAC7.html)
DK (1) DK139356B (cg-RX-API-DMAC7.html)
ES (1) ES383643A1 (cg-RX-API-DMAC7.html)
FR (1) FR2068537B1 (cg-RX-API-DMAC7.html)
GB (1) GB1264775A (cg-RX-API-DMAC7.html)
NL (1) NL7013663A (cg-RX-API-DMAC7.html)
NO (1) NO135141C (cg-RX-API-DMAC7.html)
ZA (1) ZA704981B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2130393C3 (de) * 1970-06-22 1981-02-26 E.R. Squibb & Sons Inc., New York, N.Y. (V.St.A.) 6,7-Dihydroxy -5,6,7,8-tetrahydronaphthyloxyaminopropanole und ihre Salze mit Säuren sowie ihre Verwendung bei der Bekämpfung von Herzerkrankungen
GB1464950A (en) * 1973-05-03 1977-02-16 Squibb & Sons Inc Naphthalene derivatives
GB1458392A (en) * 1973-11-09 1976-12-15 Ici Ltd Optically-active 1-aryloxy-2,3-epoxypropane derivatives
CH621330A5 (cg-RX-API-DMAC7.html) * 1976-05-14 1981-01-30 Sandoz Ag
JPS5334024U (cg-RX-API-DMAC7.html) * 1976-08-31 1978-03-25
IT1113029B (it) * 1979-03-01 1986-01-20 Simes Processo per la separazione dei due isomeri ottici del moprololo e composizioni farmaceutiche dell'antipodo levogiro
US5245080A (en) * 1989-02-20 1993-09-14 Jouveinal Sa (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-N-propylamine, process for preparing it and its therapeutical use
US5266599A (en) * 1989-02-20 1993-11-30 Jouveinal S.A. Use of (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-n-propylamine to increase gastric discharge in a subject
ES2065278B1 (es) * 1993-06-24 1995-09-01 Medichem Sa Procedimiento de obtencion enantioselectivo del levobunolol.
RS20050890A (sr) * 2003-05-30 2007-12-31 Ranbaxy Laboratories Limited, Supstituisani pirol derivati
WO2007054896A1 (en) * 2005-11-08 2007-05-18 Ranbaxy Laboratories Limited Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
CL2007000667A1 (es) * 2006-03-14 2008-03-14 Ranbaxi Lab Ltd Composicion farmaceutica que comprende al acido 7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]pirrol-1-il]-3,5-dihidroxi-heptanoico o una sal y al menos un agente estabilizante; procedimiento de preparacion, util en e
MX2009000439A (es) * 2006-07-14 2009-02-04 Ranbaxy Lab Ltd Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas.
WO2008112287A1 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2974148A (en) * 1959-03-30 1961-03-07 Smith Kline French Lab Anorexigenic preparation and method of curbing the appetite
US3641152A (en) * 1968-09-23 1972-02-08 Warner Lambert Pharmaceutical 3 4-dihydronaphthalenoneoxy-2-hydroxy-propylamines

Also Published As

Publication number Publication date
GB1264775A (cg-RX-API-DMAC7.html) 1972-02-23
DK139356B (da) 1979-02-05
DE2046043B2 (de) 1978-03-30
ES383643A1 (es) 1976-06-01
CH540882A (de) 1973-08-31
NO135141B (cg-RX-API-DMAC7.html) 1976-11-08
BR7022215D0 (pt) 1973-04-26
DE2046043A1 (de) 1971-03-25
US3649691A (en) 1972-03-14
FR2068537A1 (cg-RX-API-DMAC7.html) 1971-08-27
NO135141C (cg-RX-API-DMAC7.html) 1977-02-16
ZA704981B (en) 1971-07-28
FR2068537B1 (cg-RX-API-DMAC7.html) 1974-02-01
DK139356C (cg-RX-API-DMAC7.html) 1979-08-20
JPS494218B1 (cg-RX-API-DMAC7.html) 1974-01-31
NL7013663A (cg-RX-API-DMAC7.html) 1971-03-19
DE2046043C3 (de) 1978-12-14

Similar Documents

Publication Publication Date Title
BE755071A (fr) Procede de resolution de la dl-5-/3-(terbutylamino)-2- hydroxy-propoxy/-3,4-dihydro-1(2h) naphtalenone
NL7415624A (nl) Werkwijze ter bereiding van een elektrofoto- grafische ontwikkelaar.
CH550235A (fr) Procede de preparation de nouvelles diphenylamines.
BE757999A (fr) Procede de preparation de bromonitro-alcools.
BG21208A3 (bg) Метод за получаване на 1- алилокси-2- хидрокси -3- алкинилами- нопропани
NO138304C (no) Opploesningsanalysator.
BG25804A3 (bg) Метод за получаване на псевдотризахариди
BG27079A3 (bg) Метод за получаване на 2,2,6,6-тетраметил-4-оксипиперидин
BE765185A (fr) Procede de fonderie
BE799963A (fr) Procede de preparation de poly-(halogenures de vinyle),
BG27081A3 (bg) Метод за получаване на 2,2,6,6-тетраметил-4- оксипиперидин
CH550151A (fr) Procede de preparation de nouvelles iodomethylsulfones.
BG22820A3 (bg) Метод за получаване на пиразолони-5
IT991744B (it) Apparecchio per la prova delle con nessioni circuitali
NO137817C (no) Apparat for bygging av skip.
BE821895A (fr) Procede de preparation de 4-amino-diphenylamine
CH553785A (fr) Procede de preparation de nouvelles dibenzoazepines.
BE837825A (fr) Procede pour extraire de longs tubes
BG24408A3 (bg) Метод за получаване на бис-2-метил-3-хидрокси-4-хидрокси-метил- придил-5-метил-тиокарбонат
BG27747A3 (bg) Метод за получаване на субституирани епоксиетани
CH551937A (fr) Procede de preparation de saligenol.
CH548964A (fr) Procede de preparation de tetrahydro-cyclopropa (b)naphtalenes.
BE764420A (fr) Procede de preparation de sulfochlorures fluores
SU570462A1 (ru) Устройство дл холодной ломки проката
BE808664A (fr) Procede de conversion